Prostate-specific antigen

• Development and clinical potential of (18)F-PSiMA for prostate cancer PET imaging
• Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI
• PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study
• Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysis
• Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial
• A pH/STEAP Cascade-Responsive Nanomedicine with Self-Supplied Peroxide for Precise Chemodynamic Therapy
• Extra-axial small cell prostate carcinoma intracranial metastasis: illustrative case
• The effect of flavonoid and subclasses supplementation on prostate specific antigen, hormonal parameters and prostate cancer risk: a systematic review and meta-analysis of randomized controlled trials

The Prostate-specific antigen test is a blood test to help detect prostate cancer